Who
George M. Jenkins
Director
Company insider
Files Form 4 as: Director, Palvella Therapeutics.
In numbers
- Trades disclosed
- 46
- Buys
- 4
- Sells
- 6
- Bought
- $1.3M
- Sold
- $11.9M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 13 Dec 2024
- Last trade
- 14 Oct 2026
- Last filed
- 14 Oct 2026
Companies traded
Activity over time
1 Dec 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Oct 2026filed 14 Oct 2026 | PVLA Palvella TherapeuticsBiotechnology | SEC FORM 4 Sold | $58K476 at $121.14 | filing |
| 14 Oct 2026filed 14 Oct 2026 | PVLA Palvella TherapeuticsBiotechnology | SEC FORM 4 Sold | $254K2,072 at $122.62 | filing |
| 14 Oct 2026filed 14 Oct 2026 | PVLA Palvella TherapeuticsBiotechnology | SEC FORM 4 Sold | $321K2,604 at $123.29 | filing |
| 14 Oct 2026filed 14 Oct 2026 | PVLA Palvella TherapeuticsBiotechnology | SEC FORM 4 Sold | $114K920 at $124.37 | filing |
| 14 Oct 2026filed 14 Oct 2026 | PVLA Palvella TherapeuticsBiotechnology | SEC FORM 4 Sold | $75K597 at $125.33 | filing |
| 14 Oct 2026filed 14 Oct 2026 | PVLA Palvella TherapeuticsBiotechnology | SEC FORM 4 Sold | $64K505 at $126.55 | filing |
| 13 Oct 2026filed 14 Oct 2026 | PVLA Palvella TherapeuticsBiotechnology | SEC FORM 4 Sold | $77K579 at $132.40 | filing |
| 13 Oct 2026filed 14 Oct 2026 | PVLA Palvella TherapeuticsBiotechnology | SEC FORM 4 Sold | $123K922 at $133.72 | filing |
| 13 Oct 2026filed 14 Oct 2026 | PVLA Palvella TherapeuticsBiotechnology | SEC FORM 4 Sold | $258K2,004 at $128.52 | filing |
| 13 Oct 2026filed 14 Oct 2026 | PVLA Palvella TherapeuticsBiotechnology | SEC FORM 4 Sold | $212K1,644 at $129.23 | filing |
| 13 Oct 2026filed 14 Oct 2026 | PVLA Palvella TherapeuticsBiotechnology | SEC FORM 4 Sold | $129K990 at $130.48 | filing |
| 13 Oct 2026filed 14 Oct 2026 | PVLA Palvella TherapeuticsBiotechnology | SEC FORM 4 Sold | $136K1,035 at $131.49 | filing |
| 12 Oct 2026filed 14 Oct 2026 | PVLA Palvella TherapeuticsBiotechnology | SEC FORM 4 Sold | $676K5,095 at $132.62 | filing |
| 12 Oct 2026filed 14 Oct 2026 | PVLA Palvella TherapeuticsBiotechnology | SEC FORM 4 Sold | $328K2,458 at $133.25 | filing |
| 12 Oct 2026filed 14 Oct 2026 | PVLA Palvella TherapeuticsBiotechnology | SEC FORM 4 Sold | $448K3,335 at $134.21 | filing |
| 12 Oct 2026filed 14 Oct 2026 | PVLA Palvella TherapeuticsBiotechnology | SEC FORM 4 Sold | $196K1,447 at $135.50 | filing |
| 12 Oct 2026filed 14 Oct 2026 | PVLA Palvella TherapeuticsBiotechnology | SEC FORM 4 Sold | $111K817 at $136.44 | filing |
| 15 Sep 2026filed 15 Sep 2026 | PVLA Palvella TherapeuticsBiotechnology | SEC FORM 4 Sold | $143K954 at $149.38 | filing |
| 15 Sep 2026filed 15 Sep 2026 | PVLA Palvella TherapeuticsBiotechnology | SEC FORM 4 Sold | $40K263 at $150.40 | filing |
| 15 Sep 2026filed 15 Sep 2026 | PVLA Palvella TherapeuticsBiotechnology | SEC FORM 4 Sold | $85K560 at $151.33 | filing |
News
Insider Selling: Palvella Therapeutics (NASDAQ:PVLA) Director Sells $1,758,290.88 in StockPVLA · tickerreport.com · 17 Oct 2026Palvella Therapeutics to Present Phase 3 SELVA and Phase 2 TOIVA Results, Along With New Pediatric Analyses, at 2026 PeDRA Annual ConferencePVLA · manilatimes.net · 15 Oct 2026Palvella Therapeutics (NASDAQ:PVLA) Director Sells $935,202.64 in StockPVLA · themarketsdaily.com · 15 Oct 2026
0 headlines in the last 90 days name George M. Jenkins; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.